US Archives - Page 184 of 223 - European Medical Journal

Predictors of Psoriatic Arthritis in Juvenile Arthritis

Insights into predicting psoriatic arthritis (PsA) in juvenile idiopathic arthritis (JIA) patients, 18 years after their initial diagnosis, were shared in a recent study.

Burn Patients Face Pneumonia Risk Surge

A newly published study highlights a critical connection between inhalation injury severity and the risk of developing nosocomial pneumonia (NP) in burn patients.

Can Exercise and Brain Stimulation Help Patients With ALS?

A recent meta-analysis sheds light on nonpharmacologic treatments for amyotrophic lateral sclerosis (ALS), specifically active exercise and noninvasive brain stimulation (NIBS).

Genomic Testing Guides Chemotherapy Choices in Breast Cancer: SABCS 2024

In this study, patients with a recurrence scores greater than 31 exhibited significant improvements in survival outcomes when treated with taxane and anthracycline-based chemotherapy.

AI Technology Offers Hope for Faster Diagnosis of Infantile Spasms: AES 2024

AI-powered video analysis could transform the diagnosis of infantile spasms, a severe form of epilepsy in babies, by enabling early detection and treatment, according to new research.

Tamoxifen Reduces Recurrence for Patients with 'Good-Risk' Ductal Carcinoma In Situ: SABCS 2024

Findings, presented at SABCS 2024, support tamoxifen as an effective adjuvant therapy for reducing recurrence in women with “good-risk” DCIS who opt to skip RT.

Lessons from HIV/AIDS and COVID-19

The global challenges posed by HIV/AIDS and COVID-19 provide critical insights for managing future infectious disease outbreaks, according to a recent study by Anthony S Fauci and Gregory K Folkers.

Thin Melanomas: A Critical 0.8 mm Threshold

A recent cohort study involving 144,447 participants has found a crucial threshold in melanoma risk for tumors with a Breslow thickness between 0.8 and 1.0 mm.

A Guide to Chronic Hand Eczema

Chronic Hand Eczema (CHE) is a condition that can go under-recognized despite its significant impact on patients. With l.imited guidance..

Prof Yoshiya Tanaka

Consultant Rheumatologist; Chairman, First Department of Internal Medicine; Dean, Graduate School of Medical Science, University of…